Antiangiogenic Effect of ZD1839 against Murine Renal Cell Carcinoma (RENCA) in an Orthotopic Mouse Model

Publisher： Karger

E-ISSN： 1423-0399|75|2|159-166

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.75, Iss.2, 2008-07, pp. : 159-166

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Establishment and characterization of an orthotopic sinonasal squamous cell carcinoma mouse model

By  

HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol. 37, Iss. 12, 2015-12 ,pp. : 1769-1775

John Wiley & Sons Inc

Access to resources Recommend Favorite

Interferon-α Promotes the Anti-Proliferative Effect of Gefitinib (ZD1839) on Human Colon Cancer Cell Lines

By  

Oncology, Vol. 69, Iss. 3, 2005-10 ,pp. : 224-238

Karger

Access to resources Recommend Favorite

Preclinical Evaluation of ZD1839 Alone or in Combination with Oxaliplatin in a Panel of Human Tumor Cell Lines – Implications for Clinical Use

By  

Oncology Research and Treatment, Vol. 28, Iss. 10, 2005-09 ,pp. : 482-488

Karger

Access to resources Recommend Favorite

Metformin decreases IL‐22 secretion to suppress tumor growth in an orthotopic mouse model of hepatocellular carcinoma

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 136, Iss. 11, 2015-06 ,pp. : 2556-2565

John Wiley & Sons Inc

Access to resources Recommend Favorite

New Anti-Angiogenic Targeted Therapy in Advanced Renal Cell Carcinoma (RCC):Current Status and Future Prospects

By  

Reviews on Recent Clinical Trials, Vol. 3, Iss. 2, 2008-05 ,pp. : 97-103

Bentham Science Publishers

Access to resources Recommend Favorite